Clinical Trials Browser

Phase 2 × Breast Diseases × Trabectedin × Clear all

NCT00050427 2011-04-28

A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer

Phase 2 Completed

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Skin Diseases